{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-23-012783","form_type":"8-K","ticker":"EDSA","cik":"0001540159","company_name":"Edesa Biotech, Inc.","filed_at":"2023-10-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.464520+00:00","generated_at":"2026-06-10T01:38:26.492408+00:00","sec_items":["3.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Edesa Biotech announces 1-for-7 reverse share split effective October 11, 2023","bullets":["Reverse split reduces outstanding shares from ~21.5M to ~3.07M; no change in proportional ownership.","No fractional shares issued; fractions rounding per British Columbia law.","Adjustments made to equity awards and warrants exercise prices and shares.","Shareholder approval not required under British Columbia corporate law.","Common shares continue trading under symbol EDSA with new CUSIP 27966L306."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-23-012783","json":"https://secwatch.observer/filing/0001654954-23-012783.json","markdown":"https://secwatch.observer/filing/0001654954-23-012783.md","text":"https://secwatch.observer/filing/0001654954-23-012783.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423012783/0001654954-23-012783-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1540159/000165495423012783/edsa_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T01:38:26.492408+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}